- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04903067
An Investigation Into the Relationship Between Dietary Intake and Health-related Quality of Life in Children and Young People With Juvenile Idiopathic Arthritis (JIA)
"Physical activity and diet in children and young people with arthritis" A qualitative study of exploring stake holder's experiences.
Juvenile Idiopathic Arthritis (JIA) is the most common type of arthritis in children under the age of 16. The disease and its therapeutic management can cause serious long-term complications, which affect general activities and quality of life. The lack of specific guidelines for safe physical activity and appropriate management of any nutritional deficit aiming our study to find out your views and opinions about the needs of children and young people with juvenile idiopathic arthritis. We want to improve our knowledge about the impact of physical activity and eating habit on juvenile idiopathic arthritis and we want to develop a tool to help evaluate care. Few studies targeting quality of life and wellbeing in children adolescent populations have adopted the diet and physical activity perspective or approaches, consequently, this research project will help to address this gap through:
- Interview: to look at young people's current experiences with JIA as well as their parents/caregivers and health care professionals. Study findings will provide a snapshot of the current experiences of participants, helping to improve our knowledge about JIA, physical activity, and diet. Qualitative studies exploring people perspectives on their experiences, when collected systematically, adds valuable depth, insight and understanding into the issues related to JIA not possible through quantitative methodologies. This study uses a qualitative approach known as framework methodology to understand stakeholder's experience of what helps and what hinders improving the quality of life in children and young adult with JIA. 21-30 stakeholders will be recruited in Oxford UK, to take part in individual semi-structured guided interviews lasting approximately one hour. Participant responses will be transcribed by the chief investigator and analysed to extract themes that will answer the research question.
- Delphi study: which aims to develop a diet and physical activity intervention for children and young adult with JIA.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
"Physical activity and diet in children and young people with arthritis" A qualitative study of exploring stake holder's experiences.
Juvenile Idiopathic Arthritis (JIA) is the most common type of arthritis in children under the age of 16. The disease and its therapeutic management can cause serious long-term complications, which affect general activities and quality of life. The lack of specific guidelines for safe physical activity and appropriate management of any nutritional deficit aiming our study to find out your views and opinions about the needs of children and young people with juvenile idiopathic arthritis. We want to improve our knowledge about the impact of physical activity and eating habit on juvenile idiopathic arthritis and we want to develop a tool to help evaluate care. Few studies targeting quality of life and wellbeing in children adolescent populations have adopted diet and physical activity perspective or approaches, consequently this research project will help to address this gap through:
- Systematic review: to evaluate current evidence about diet, health and health related quality of life in children and young adult with JIA.
- Interview: to look at young people's current experiences with JIA as well as their parents/caregivers and health care professionals. Study findings will provide a snapshot of current experiences of participants, helping to improve our knowledge about JIA, physical activity, and diet. Qualitative studies exploring people perspectives on their experiences, when collected systematically, adds valuable depth, insight and understanding into the issues related to JIA not possible through quantitative methodologies. This study uses a qualitative approach known as framework methodology to understand stakeholder's experience of what helps and what hinders improving the quality of life in children and young adult with JIA. 21-30 stakeholders will be recruited in Oxford UK, to take part in individual semi-structured guided interviews lasting approximately one hour. Participant responses will be transcribed by the chief investigator (PhD student) and analysed to extract themes that will answer the research question.
- Delphi study: which aims to develop diet and physical activity intervention for children and young adult with JIA.
This protocol covers the second and third approaches only (interview and Delphi).
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studiecontact
- Naam: Najmeh Zare, phd student
- Telefoonnummer: +4401865483293
- E-mail: 18106168@brookes.ac.uk
Studie Contact Back-up
- Naam: Sarah Quiinton, Dr
- Telefoonnummer: +44 (0) 1865 485694
- E-mail: sequinton@brookes.ac.uk
Studie Locaties
-
-
Oxfordshire
-
Oxford, Oxfordshire, Verenigd Koninkrijk, ox3obp
- Werving
- Najmeh Zare
-
Contact:
- Sarah Quinton, Dr
- Telefoonnummer: +44 (0) 1865 485694
- E-mail: sequinton@brookes.ac.uk
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
A) Patients
- Male or female, age range 9 to 18 years old.
- Diagnosed with JIA.
- Speaking and understanding English.
- Willing and able to provide consent if 16-18 years old, or have a parent/carer to provide consent and able to provide assent if the participant is <16.
- Having the access to telephone/video call for those who wish to have distance interview.
B) Parent/Carer
- parent or caregiver of a child with JIA.
- Willing and able to give informed consent for their own and their child's participation (if the child is under 16 years of age).
- Having the access to telephone/video call for those who wish to have distance interview.
- Speaking and understanding English. C) Healthcare professionals
- Willing and able to give informed consent.
- Clinical HCP with at least 2-year experience in treating children and young people with JIA.
- Academic in the field of clinical research in the treatment of JIA.
- Having the access to telephone/video call for those who wish to have distance interview.
- Speaking and understanding English.
Exclusion Criteria:
Individuals will be excluded from the study if ANY of the following apply:
A) Patient
- They have been diagnosed JIA but older than 18 years old.
- Unable to speak and understand English. B) Healthcare professionals
HCP with insufficient experience in JIA management.
- They have less than two years of managing/treating JIA patients.
- They have worked in this field but have stopped for two years or more.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
study one interviews
Tijdsspanne: one hour
|
views and opinions of participants
|
one hour
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
study two Delphi
Tijdsspanne: one hour
|
consensus of views and opinions
|
one hour
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 110611
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .